On July 26, 2023, FDA released a guidance document on a program at FDA’s Center for Drug Evaluation and Research (CDER) to publicize a listing of accepted voluntary consensus standards…
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…